Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Polyarticular course JIA “generally improved over time” ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Understanding the subtypes of juvenile idiopathic arthritis can help adult and pediatric ...

Real-world data suggest anti-TNF biosimilars for juvenile idiopathic arthritis offer comparable efficacy and safety to their brand name counterparts. As high-cost originator biologics continue to ...

A couple who walked and ran two miles every day for a month to raise awareness of child arthritis say it was a challenge to get their son diagnosed. Dean and Becki Ranyard from Spennymoor, County ...

Juvenile idiopathic arthritis (JIA), a type of arthritis commonly occurring in children, is a chronic, inflammatory condition that affects the joints, causing pain, swelling, stiffness, and limiting ...

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease affecting children. A significant complication of JIA is involvement of the temporomandibular joint (TMJ), where ...

Juvenile idiopathic arthritis (JIA), a type of arthritis commonly occurring in children, is a chronic, inflammatory condition that affects the joints, causing pain, swelling, stiffness, and limiting ...

NEW YORK--(BUSINESS WIRE)--PIF Partners announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its proprietary investigational ...

Arthritis is not just an old person's disease. Children can get arthritis too, and some forms can be deadly. July is Juvenile Arthritis Awareness Month. A local boy is doing what he can to spread ...

Relapse occurred in over half of patients with juvenile idiopathic arthritis (JIA) within a year of stopping biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD) treatment after ...

Juvenile idiopathic arthritis (JIA) encompasses a heterogeneous group of chronic inflammatory arthritides that manifest before the age of 16. Despite its uncertain aetiology, research has increasingly ...